[Radiofrequency thermal ablation combined with arterial embolization for primary liver cancer].
OBJECTIVE
To explore the short-term effect of radiofrequency ablation (RFA) combined with arterial embolization in treating patients with primary liver cancer.


METHODS
Thirty patients with primary liver cancer received the combined treatment and the pre- and post-operative alpha-fetoprotein (AFP) levels, imaging features, and liver function were investigated along with observation of the incidence of complications to evaluate the therapeutic effects.


RESULTS
The post-operative AFP positivity and the tumor density were significantly reduced in these patients, and their one-year survival rate reached 96.7% with only minor complications observed.


CONCLUSIONS
RFA combined with arterial embolization is effective for primary liver cancer.
Cui
Shu-zhong
SZ
Guangzhou Tumor Hospital and Clinical Center for Cancer Research of Guangzhou Medical College, Guangzhou 510095, China.
Liu
Hai-ying
HY
Tang
Yun-qiang
YQ
Hu
Wei-min
WM
Wang
Jia-kang
JK
Li
Jian-chang
JC
Song
Tao
T
Lin
Sheng-qu
SQ
D000328:Adult; D000368:Aged; D017115:Catheter Ablation; D016461:Chemoembolization, Therapeutic; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D015996:Survival Rate; D014057:Tomography, X-Ray Computed; D000509:alpha-Fetoproteins / Q000032:analysis
D000509:alpha-Fetoproteins